Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database of clinical information and plasma, serum, and tissue samples from cholestatic children to facilitate research and to perform clinical, epidemiological and therapeutic trials in these important pediatric liver diseases.
Biliary Atresia, Neonatal Cholestasis
Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database of clinical information and plasma, serum, and tissue samples from cholestatic children to facilitate research and to perform clinical, epidemiological and therapeutic trials in these important pediatric liver diseases.
A Prospective Database of Infants With Cholestasis
-
Children's Hospital Los Angeles, Los Angeles, California, United States, 90027
University of California, San Francisco, California, United States, 94143
Children's Hospital Colorado, Aurora, Colorado, United States, 80045
Children's Healthcare of Atlanta - Emory University, Atlanta, Georgia, United States, 30322
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States, 60614
Riley Hospital for Children, Indianapolis, Indiana, United States, 46202
Johns Hopkins School of Medicine, Baltimore, Maryland, United States, 21287
Washington University School of Medicine, Saint Louis, Missouri, United States, 63110
Mount Sinai Medical Center, New York, New York, United States, 10029
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, 45229
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
to 6 Months
ALL
No
Arbor Research Collaborative for Health,
Saul Karpen, MD, PhD, STUDY_CHAIR, Children's Healthcare of Atlanta - Emory University
Ed Doo, MD, STUDY_DIRECTOR, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
John Magee, MD, PRINCIPAL_INVESTIGATOR, University of Michigan Medical Center, Ann Arbor
Lisa Henn, PhD, PRINCIPAL_INVESTIGATOR, Arbor Research Collaborative of Health
Averell Sherker, MD, STUDY_DIRECTOR, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2029-05